188 related articles for article (PubMed ID: 28182003)
21. Astragalus extract inhibits proliferation but enhances apoptosis in gastric cancer.
Wang Z; Dong L; Zhen Y; Wang Y; Qi D; Xu A; Meng X; Li W
Pak J Pharm Sci; 2016 Sep; 29(5):1473-1482. PubMed ID: 27731799
[TBL] [Abstract][Full Text] [Related]
22. Geranylnaringenin (CG902) inhibits constitutive and inducible STAT3 activation through the activation of SHP-2 tyrosine phosphatase.
Jin Y; Yoon YJ; Jeon YJ; Choi J; Lee YJ; Lee J; Choi S; Nash O; Han DC; Kwon BM
Biochem Pharmacol; 2017 Oct; 142():46-57. PubMed ID: 28666623
[TBL] [Abstract][Full Text] [Related]
23. Nintedanib (BIBF-1120) inhibits hepatocellular carcinoma growth independent of angiokinase activity.
Tai WT; Shiau CW; Li YS; Chang CW; Huang JW; Hsueh TT; Yu HC; Chen KF
J Hepatol; 2014 Jul; 61(1):89-97. PubMed ID: 24657398
[TBL] [Abstract][Full Text] [Related]
24. Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases.
Lee JH; Chiang SY; Nam D; Chung WS; Lee J; Na YS; Sethi G; Ahn KS
Cancer Lett; 2014 Apr; 345(1):140-8. PubMed ID: 24333736
[TBL] [Abstract][Full Text] [Related]
25. γ-Tocotrienol but not γ-tocopherol blocks STAT3 cell signaling pathway through induction of protein-tyrosine phosphatase SHP-1 and sensitizes tumor cells to chemotherapeutic agents.
Kannappan R; Yadav VR; Aggarwal BB
J Biol Chem; 2010 Oct; 285(43):33520-33529. PubMed ID: 20720018
[TBL] [Abstract][Full Text] [Related]
26. A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3.
Huang CY; Tai WT; Hsieh CY; Hsu WM; Lai YJ; Chen LJ; Shiau CW; Chen KF
Cancer Lett; 2014 Jul; 349(2):136-43. PubMed ID: 24735751
[TBL] [Abstract][Full Text] [Related]
27. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
28. Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibition.
Zhang T; Li S; Li J; Yin F; Hua Y; Wang Z; Lin B; Wang H; Zou D; Zhou Z; Xu J; Yi C; Cai Z
Cell Death Dis; 2016 Oct; 7(10):e2421. PubMed ID: 27735939
[TBL] [Abstract][Full Text] [Related]
29. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
[TBL] [Abstract][Full Text] [Related]
30. SHP-1/STAT3 Interaction Is Related to Luteolin-Induced Myocardial Ischemia Protection.
Liu D; Luo H; Qiao C
Inflammation; 2022 Feb; 45(1):88-99. PubMed ID: 34460026
[TBL] [Abstract][Full Text] [Related]
31. Cryptotanshinone potentiates the antitumor effects of doxorubicin on gastric cancer cells via inhibition of STAT3 activity.
Wang J; Zhang G; Dai C; Gao X; Wu J; Shen L; Chen Z; Liu P
J Int Med Res; 2017 Feb; 45(1):220-230. PubMed ID: 28222632
[TBL] [Abstract][Full Text] [Related]
32. Ginkgolic Acid C 17:1, Derived from Ginkgo biloba Leaves, Suppresses Constitutive and Inducible STAT3 Activation through Induction of PTEN and SHP-1 Tyrosine Phosphatase.
Baek SH; Lee JH; Kim C; Ko JH; Ryu SH; Lee SG; Yang WM; Um JY; Chinnathambi A; Alharbi SA; Sethi G; Ahn KS
Molecules; 2017 Feb; 22(2):. PubMed ID: 28208828
[TBL] [Abstract][Full Text] [Related]
33. Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1.
Ahn KS; Sethi G; Sung B; Goel A; Ralhan R; Aggarwal BB
Cancer Res; 2008 Jun; 68(11):4406-15. PubMed ID: 18519703
[TBL] [Abstract][Full Text] [Related]
34. Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity.
Jeon YJ; Jung SN; Yun J; Lee CW; Choi J; Lee YJ; Han DC; Kwon BM
Cancer Sci; 2015 Apr; 106(4):413-20. PubMed ID: 25611086
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of STAT3 signaling and induction of SHP1 mediate antiangiogenic and antitumor activities of ergosterol peroxide in U266 multiple myeloma cells.
Rhee YH; Jeong SJ; Lee HJ; Lee HJ; Koh W; Jung JH; Kim SH; Sung-Hoon K
BMC Cancer; 2012 Jan; 12():28. PubMed ID: 22260501
[TBL] [Abstract][Full Text] [Related]
36. Stat3-siRNA inhibits the growth of gastric cancer in vitro and in vivo.
Sun Y; Guo BF; Xu LB; Zhong JT; Liu ZW; Liang H; Wen NY; Yun WJ; Zhang L; Zhao XJ
Cell Biochem Funct; 2015 Oct; 33(7):495-502. PubMed ID: 26486443
[TBL] [Abstract][Full Text] [Related]
37. Calpain/SHP-1 interaction by honokiol dampening peritoneal dissemination of gastric cancer in nu/nu mice.
Liu SH; Wang KB; Lan KH; Lee WJ; Pan HC; Wu SM; Peng YC; Chen YC; Shen CC; Cheng HC; Liao KK; Sheu ML
PLoS One; 2012; 7(8):e43711. PubMed ID: 22937084
[TBL] [Abstract][Full Text] [Related]
38. STAT3 mediates regorafenib-induced apoptosis in hepatocellular carcinoma.
Tai WT; Chu PY; Shiau CW; Chen YL; Li YS; Hung MH; Chen LJ; Chen PL; Su JC; Lin PY; Yu HC; Chen KF
Clin Cancer Res; 2014 Nov; 20(22):5768-76. PubMed ID: 25248379
[TBL] [Abstract][Full Text] [Related]
39. SHP-1 is a target of regorafenib in colorectal cancer.
Fan LC; Teng HW; Shiau CW; Lin H; Hung MH; Chen YL; Huang JW; Tai WT; Yu HC; Chen KF
Oncotarget; 2014 Aug; 5(15):6243-51. PubMed ID: 25071018
[TBL] [Abstract][Full Text] [Related]
40. Active Hexose Correlated Compound (AHCC) Inhibits the Proliferation of Ovarian Cancer Cells by Suppressing Signal Transducer and Activator of Transcription 3 (STAT3) Activation.
Choi JY; Lee S; Yun SM; Suh DH; Kim K; No JH; Jeong EH; Kim YB
Nutr Cancer; 2018 Jan; 70(1):109-115. PubMed ID: 29111786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
